News on protein analysis, clinical proteomics, biomarkers in genetics, genomics, and molecular diagnostics.
Issues like small sample cohorts and the use of inappropriate statistical analyses raise questions about the robustness of some proteomic studies.
The company plans to develop tests for prostate cancer risk assessment, prostate cancer screening, and breast cancer screening.
The researchers have devised an SRM workflow using extensive fractionation and multiple dimensions of separation to measure proteins at picograms per mL levels.
Investigators identified candidate protein markers from aptamer-based proteomic profiles of samples from women with or without late-onset preeclampsia.
The company posted Q2 revenues of $558.3 million, up from $536.6 million in Q2 2016 and beating the average Wall Street estimate of $553.1 million.
Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.
By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.
Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.
In Nature this week: a Danish reference genome, and more.